Cargando…

Mouse DC-SIGN/CD209a as Target for Antigen Delivery and Adaptive Immunity

The efficacy of vaccination studies aimed at targeting antigens to human DC-SIGN (hDC-SIGN) have been notoriously difficult to study in vivo, as eight dendritic cell-specific intercellular adhesion molecule-3 grabbing non-integrin (DC-SIGN) homologs have been described in mice. CD209a/SIGNR5 has bee...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schetters, Sjoerd T. T., Kruijssen, Laura J. W., Crommentuijn, Matheus H. W., Kalay, Hakan, Ochando, Jordi, den Haan, Joke M. M., Garcia-Vallejo, Juan J., van Kooyk, Yvette
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5949514/ https://www.ncbi.nlm.nih.gov/pubmed/29867967 http://dx.doi.org/10.3389/fimmu.2018.00990

Ejemplares similares

Immunological dynamics after subcutaneous immunization with a squalene‐based oil‐in‐water adjuvant
por: Schetters, Sjoerd T. T., et al.
Publicado: (2020)

Glycan-based DC-SIGN targeting to enhance antigen cross-presentation in anticancer vaccines
por: García-Vallejo, Juan J., et al.
Publicado: (2013)

Monocyte-derived APCs are central to the response of PD1 checkpoint blockade and provide a therapeutic target for combination therapy
por: Schetters, Sjoerd T T, et al.
Publicado: (2020)

Immune involvement of the contralateral hemisphere in a glioblastoma mouse model
por: Crommentuijn, Matheus H W, et al.
Publicado: (2020)

Toll-Like Receptor 4 Triggering Promotes Cytosolic Routing of DC-SIGN-Targeted Antigens for Presentation on MHC Class I
por: Horrevorts, Sophie K., et al.
Publicado: (2018)

Palmitoylated antigens for the induction of anti-tumor CD8(+) T cells and enhanced tumor recognition
por: Stolk, Dorian A., et al.
Publicado: (2021)

Bacterial inclusion bodies function as vehicles for dendritic cell-mediated T cell responses
por: Schetters, Sjoerd T. T., et al.
Publicado: (2019)

Analytical Tools for the Study of Cellular Glycosylation in the Immune System
por: van Kooyk, Yvette, et al.
Publicado: (2013)

Neuroinflammation: Microglia and T Cells Get Ready to Tango
por: Schetters, Sjoerd T. T., et al.
Publicado: (2018)

Glyco-Dendrimers as Intradermal Anti-Tumor Vaccine Targeting Multiple Skin DC Subsets
por: Duinkerken, Sanne, et al.
Publicado: (2019)

Activation of CD8(+) T Cell Responses after Melanoma Antigen Targeting to CD169(+) Antigen Presenting Cells in Mice and Humans
por: van Dinther, Dieke, et al.
Publicado: (2019)

Antigen targeting reveals splenic CD169(+) macrophages as promoters of germinal center B‐cell responses
por: Veninga, Henrike, et al.
Publicado: (2015)

CD209L/L-SIGN and CD209/DC-SIGN act as receptors for SARS-CoV-2
por: Amraei, Razie, et al.
Publicado: (2021)

CD209L/L-SIGN and CD209/DC-SIGN Act as Receptors for SARS-CoV-2
por: Amraei, Razie, et al.
Publicado: (2021)

Sialic acids in pancreatic cancer cells drive tumour-associated macrophage differentiation via the Siglec receptors Siglec-7 and Siglec-9
por: Rodriguez, Ernesto, et al.
Publicado: (2021)

Variants in the DC-SIGN–Encoding Gene CD209 and Susceptibility to Tuberculosis
Publicado: (2006)

Optimization of Liposomes for Antigen Targeting to Splenic CD169(+) Macrophages
por: Nijen Twilhaar, Maarten K., et al.
Publicado: (2020)

CNS myelin induces regulatory functions of DC-SIGN–expressing, antigen-presenting cells via cognate interaction with MOG
por: García-Vallejo, J.J., et al.
Publicado: (2014)

The Consequences of Multiple Simultaneous C-Type Lectin–Ligand Interactions: DCIR Alters the Endo-Lysosomal Routing of DC-SIGN
por: García-Vallejo, Juan J., et al.
Publicado: (2015)

Promoter Variation in the DC-SIGN–Encoding Gene CD209 Is Associated with Tuberculosis
por: Barreiro, Luis B, et al.
Publicado: (2006)

C-type Lectin CD209L/L-SIGN and CD209/DC-SIGN: Cell Adhesion Molecules Turned to Pathogen Recognition Receptors
por: Rahimi, Nader
Publicado: (2020)

Interaction of the Capsular Polysaccharide A from Bacteroides fragilis with DC-SIGN on Human Dendritic Cells is Necessary for Its Processing and Presentation to T Cells
por: Bloem, Karien, et al.
Publicado: (2013)

DC-SIGN (CD209) Mediates Dengue Virus Infection of Human Dendritic Cells
por: Tassaneetrithep, Boonrat, et al.
Publicado: (2003)

Mycobacteria Target DC-SIGN to Suppress Dendritic Cell Function
por: Geijtenbeek, Teunis B.H., et al.
Publicado: (2003)

DC-SIGN (CD209) Promoter −336 A/G Polymorphism Is Associated with Dengue Hemorrhagic Fever and Correlated to DC-SIGN Expression and Immune Augmentation
por: Wang, Lin, et al.
Publicado: (2011)

Comparison of Protein and Peptide Targeting for the Development of a CD169-Based Vaccination Strategy Against Melanoma
por: van Dinther, Dieke, et al.
Publicado: (2018)

Dermal-Type Macrophages Expressing CD209/DC-SIGN Show Inherent Resistance to Dengue Virus Growth
por: Kwan, Wing-Hong, et al.
Publicado: (2008)

Human Milk Blocks DC-SIGN–Pathogen Interaction via MUC1
por: Koning, Nathalie, et al.
Publicado: (2015)

Targeting Mycobacterium tuberculosis Antigens to Dendritic Cells via the DC-Specific-ICAM3-Grabbing-Nonintegrin Receptor Induces Strong T-Helper 1 Immune Responses
por: Velasquez, Lis Noelia, et al.
Publicado: (2018)

DC-SIGN (CD209) Carbohydrate Recognition Domain Is Not Polymorphic in Dengue Virus-Infected Indonesian Patients
por: Wibawa, Tri, et al.
Publicado: (2015)

Proteus mirabilis Targets Atherosclerosis Plaques in Human Coronary Arteries via DC-SIGN (CD209)
por: Xue, Ying, et al.
Publicado: (2021)

Neutrophils mediate immune modulation of dendritic cells through glycosylation-dependent interactions between Mac-1 and DC-SIGN
por: van Gisbergen, Klaas P.J.M., et al.
Publicado: (2005)

Tolerogenic Immunotherapy: Targeting DC Surface Receptors to Induce Antigen-Specific Tolerance
por: Castenmiller, Charlotte, et al.
Publicado: (2021)

Fasciola hepatica glycoconjugates immuneregulate dendritic cells through the Dendritic Cell-Specific Intercellular adhesion molecule-3-Grabbing Non-integrin inducing T cell anergy
por: Rodríguez, Ernesto, et al.
Publicado: (2017)

Relationship between polymorphism of DC-SIGN (CD209) gene and the susceptibility to pulmonary tuberculosis in an eastern Chinese population
por: Zheng, Ruijuan, et al.
Publicado: (2011)

Phenotypic and Functional Properties of Human Steady State CD14(+) and CD1a(+) Antigen Presenting Cells and Epidermal Langerhans Cells
por: Fehres, Cynthia. M., et al.
Publicado: (2015)

Selective tumor antigen vaccine delivery to human CD169(+) antigen-presenting cells using ganglioside-liposomes
por: Affandi, Alsya J., et al.
Publicado: (2020)

Human Milk Oligosaccharide 2′-Fucosyllactose Inhibits Ligand Binding to C-Type Lectin DC-SIGN but Not to Langerin
por: Mukherjee, Reshmi, et al.
Publicado: (2022)

Understanding the Biology of Antigen Cross-Presentation for the Design of Vaccines Against Cancer
por: Fehres, Cynthia M., et al.
Publicado: (2014)

Skin-Resident Antigen-Presenting Cells: Instruction Manual for Vaccine Development
por: Fehres, Cynthia M., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_2u95rmkk02bkersgsfnc92k18h